MiMedx Group, Inc. (MDXG)
Company Info
ISIN | US6024961012 |
---|---|
CUSIP | 602496101 |
Sector | Healthcare |
Industry | Medical Devices |
Highlights
Market Cap | $964.49M |
---|---|
EPS (TTM) | $0.57 |
PE Ratio | 11.19 |
PEG Ratio | 2.97 |
Total Revenue (TTM) | $340.46M |
Gross Profit (TTM) | $283.61M |
EBITDA (TTM) | $74.32M |
Year Range | $5.57 - $9.27 |
Target Price | $12.20 |
Short % | 4.10% |
Short Ratio | 6.47 |
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
The chart shows the growth of an initial investment of $10,000 in MiMedx Group, Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Returns By Period
MiMedx Group, Inc. had a return of -27.25% year-to-date (YTD) and -16.93% in the last 12 months. Over the past 10 years, MiMedx Group, Inc. had an annualized return of -1.12%, while the S&P 500 had an annualized return of 10.67%, indicating that MiMedx Group, Inc. did not perform as well as the benchmark.
Period | Return | Benchmark |
---|---|---|
Year-To-Date | -27.25% | 15.38% |
1 month | -0.00% | 5.03% |
6 months | -21.72% | 6.71% |
1 year | -16.93% | 23.24% |
5 years (annualized) | 5.18% | 13.10% |
10 years (annualized) | -1.12% | 10.67% |
Monthly Returns
The table below presents the monthly returns of MDXG, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.
Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2024 | -11.74% | 5.43% | -5.64% | -20.00% | 16.07% | -3.08% | 7.50% | -8.19% | -27.25% | ||||
2023 | 39.21% | 24.29% | -29.11% | 12.32% | 53.00% | 12.80% | 22.09% | -8.05% | -1.75% | -10.01% | 18.45% | 12.87% | 215.47% |
2022 | -17.88% | 1.81% | -6.73% | -16.14% | -1.01% | -11.25% | -1.44% | 3.22% | -18.70% | 3.14% | 9.80% | -14.46% | -53.97% |
2021 | 8.15% | 0.92% | 3.94% | -5.83% | 10.21% | 17.03% | -2.00% | 20.39% | -58.94% | 13.04% | 2.34% | -13.84% | -33.48% |
2020 | -2.64% | -12.47% | -45.98% | 12.89% | -8.88% | 50.42% | 2.59% | 22.74% | -6.54% | -16.29% | 26.13% | 35.32% | 19.79% |
2019 | 47.21% | 13.85% | 17.00% | -31.62% | 89.58% | -10.99% | 29.63% | -1.90% | -4.85% | 15.71% | 28.57% | 3.98% | 323.46% |
2018 | 32.83% | -57.67% | -1.69% | 17.79% | 2.56% | -24.11% | -33.49% | 24.71% | 16.60% | -5.83% | -48.28% | -40.53% | -85.80% |
2017 | -8.80% | 6.06% | 11.20% | 33.16% | 7.80% | 9.43% | -0.07% | 8.76% | -26.98% | 6.73% | -8.75% | 8.99% | 42.33% |
2016 | -11.21% | -1.08% | 6.20% | -13.84% | 4.52% | 1.40% | -6.14% | -3.34% | 18.51% | 3.85% | 6.40% | -6.54% | -5.44% |
2015 | -29.27% | 26.92% | 0.48% | -9.62% | 10.11% | 11.98% | -7.42% | -9.51% | -0.62% | -24.56% | 23.08% | 4.58% | -18.73% |
2014 | -10.30% | -8.80% | -14.27% | -5.71% | -5.36% | 29.62% | -2.54% | 1.88% | 1.28% | 42.78% | 8.64% | 4.25% | 31.92% |
2013 | 13.28% | 5.75% | 10.65% | 35.95% | 4.05% | -1.94% | -11.33% | -1.44% | -32.41% | 27.10% | 18.87% | 38.73% | 127.60% |
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
The current rank of MDXG is 33, suggesting that the investment has average results relative to other stocks in terms of risk-adjusted performance. This ranking is determined by the cumulative values of the indicators listed below.
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for MiMedx Group, Inc. (MDXG) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Worst Drawdowns
The table below displays the maximum drawdowns of the MiMedx Group, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the MiMedx Group, Inc. was 93.84%, occurring on Mar 24, 2009. Recovery took 953 trading sessions.
The current MiMedx Group, Inc. drawdown is 64.48%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
---|---|---|---|---|---|---|
-93.84% | Apr 1, 2008 | 134 | Mar 24, 2009 | 953 | Apr 29, 2013 | 1087 |
-93.6% | Jan 30, 2018 | 217 | Dec 7, 2018 | — | — | — |
-48.65% | Jul 20, 2015 | 206 | May 11, 2016 | 246 | May 3, 2017 | 452 |
-48.34% | Jun 26, 2013 | 49 | Sep 4, 2013 | 70 | Dec 12, 2013 | 119 |
-41.76% | Jan 2, 2014 | 87 | May 7, 2014 | 112 | Oct 15, 2014 | 199 |
Volatility
Volatility Chart
The current MiMedx Group, Inc. volatility is 12.69%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.
Financials
Financial Performance
Valuation
The Valuation section provides an assessment of the market value of MiMedx Group, Inc. compared to its peers in the Medical Devices industry.
PE Ratio
The chart displays the price to earnings (P/E) ratio for MDXG in comparison to other companies of the Medical Devices industry. Currently, MDXG has a PE value of 11.2. This PE value is considered to be low compared to the rest of the industry.PEG Ratio
The chart displays the price to earnings to growth (PEG) ratio for MDXG in comparison to other companies of the Medical Devices industry. Currently, MDXG has a PEG value of 3.0. This PEG ratio is much higher than those of other companies of the industry. This might be an indicator of the company being overvalued.Historical P/E Ratio Chart
The chart below displays the historical trend of the price-to-earnings (P/E) ratio for MiMedx Group, Inc..
Loading data...
Income Statement
TTM | |
---|---|
Revenue | |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |